Aim and Scope
This journal serves as a multidisciplinary platform that integrates advances in medicine, biochemistry, molecular biology, and medical pharmacology to address contemporary challenges in human health. Its scope is divided into three main branches:
- Medicine (Miscellaneous):
- Research on innovative concepts in human biology and disease pathogenesis.
- Development of therapeutic modalities, including gene and cell therapies.
- Clinical genomics and regenerative medicine.
- High-definition medicine, early disease diagnosis, and smart wearable technologies.
- Exploring the effects of the environment on human health and the microbiome.
- Aging and its implications for health and disease.
- Reviews, perspectives, and expert commentaries on the latest trends in medicine.
- Medical Biochemistry, Genetics, and Molecular Medicine:
- Molecular mechanisms underlying disease processes.
- Cutting-edge research in genomics, proteomics, and metabolomics.
- Applications of artificial intelligence in molecular biology and precision medicine.
- Investigations into the microbiome and its interactions with genetic and environmental factors.
- The role of molecular biology in advancing regenerative and personalized medicine.
- Medical Pharmacology:
- Pharmacologic behavior of drugs and therapeutic agents in preclinical and clinical settings.
- Early clinical trials and predictions from drug chemistry for benefits and side effects.
- Evaluation of the safety and efficacy of vaccines, drugs, and medical devices.
- Advanced methodologies in pharmacology for better clinical decision-making.
- Reviews and research on the mechanisms of action, interactions, and therapeutic effects of drugs.
This journal aims to provide evidence-based insights and foster innovation across these interconnected fields, driving progress in improving human health and addressing the complexities of contemporary medicine.
